The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells
- PMID: 24515801
- PMCID: PMC4407472
- DOI: 10.1158/1541-7786.MCR-13-0567
The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells
Abstract
NR4A1 (Nur77, TR3) is an orphan nuclear receptor that is overexpressed in pancreatic cancer and exhibits pro-oncogenic activity. RNA interference of NR4A1 expression in Panc-1 cells induced apoptosis and subsequent proteomic analysis revealed the induction of several markers of endoplasmic reticulum stress, including glucose-related protein 78 (GRP78), CCAAT/enhancer-binding protein-homologous protein (CHOP), and activating transcription factor-4 (ATF-4). Treatment of pancreatic cancer cells with the NR4A1 antagonist 1,1-bis(3'-indolyl)-1-(p-hydroxyphenyl)methane (DIM-C-pPhOH) gave similar results. Moreover, both NR4A1 knockdown and DIM-C-pPhOH induced reactive oxygen species (ROS), and induction of ROS and endoplasmic reticulum stress by these agents was attenuated after cotreatment with antioxidants. Manipulation of NR4A1 expression coupled with gene expression profiling identified a number of ROS metabolism transcripts regulated by NR4A1. Knockdown of one of these transcripts, thioredoxin domain containing 5 (TXNDC5), recapitulated the elevated ROS and endoplasmic reticulum stress; thus, demonstrating that NR4A1 regulates levels of endoplasmic reticulum stress and ROS in pancreatic cancer cells to facilitate cell proliferation and survival. Finally, inactivation of NR4A1 by knockdown or DIM-C-pPhOH decreased TXNDC5, resulting in activation of the ROS/endoplasmic reticulum stress and proapoptotic pathways.
Implications: The NR4A1 receptor is pro-oncogenic, regulates the ROS/endoplasmic reticulum stress pathways, and inactivation of the receptor represents a novel pathway for inducing cell death in pancreatic cancer.
Mol Cancer Res; 12(4); 527-38. ©2014 AACR.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4407472/bin/nihms-565497-f0001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4407472/bin/nihms-565497-f0002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4407472/bin/nihms-565497-f0003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4407472/bin/nihms-565497-f0004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4407472/bin/nihms-565497-f0005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4407472/bin/nihms-565497-f0006.gif)
Similar articles
-
The nuclear orphan receptor NR4A1 regulates β1-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists.Mol Carcinog. 2017 Sep;56(9):2066-2075. doi: 10.1002/mc.22662. Epub 2017 May 9. Mol Carcinog. 2017. PMID: 28418095 Free PMC article.
-
Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS).Oncotarget. 2016 May 24;7(21):31257-69. doi: 10.18632/oncotarget.9112. Oncotarget. 2016. PMID: 27144436 Free PMC article.
-
Non-genomic effects of the NR4A1/Nur77/TR3/NGFIB orphan nuclear receptor.Steroids. 2015 Mar;95:1-6. doi: 10.1016/j.steroids.2014.12.020. Epub 2014 Dec 30. Steroids. 2015. PMID: 25555471 Review.
-
Targeting NR4A1 (TR3) in cancer cells and tumors.Expert Opin Ther Targets. 2011 Feb;15(2):195-206. doi: 10.1517/14728222.2011.547481. Epub 2011 Jan 5. Expert Opin Ther Targets. 2011. PMID: 21204731 Free PMC article. Review.
-
Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth.Cancer Res. 2010 Sep 1;70(17):6824-36. doi: 10.1158/0008-5472.CAN-10-1992. Epub 2010 Jul 21. Cancer Res. 2010. PMID: 20660371 Free PMC article.
Cited by
-
Thioredoxin Domain Containing 5 (TXNDC5): Friend or Foe?Curr Issues Mol Biol. 2024 Apr 4;46(4):3134-3163. doi: 10.3390/cimb46040197. Curr Issues Mol Biol. 2024. PMID: 38666927 Free PMC article. Review.
-
The role and mechanism of TXNDC5 in disease progression.Front Immunol. 2024 Apr 2;15:1354952. doi: 10.3389/fimmu.2024.1354952. eCollection 2024. Front Immunol. 2024. PMID: 38629066 Free PMC article. Review.
-
Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustion.Cancer Immunol Immunother. 2023 Dec;72(12):3985-3999. doi: 10.1007/s00262-023-03530-3. Epub 2023 Oct 17. Cancer Immunol Immunother. 2023. PMID: 37847301 Free PMC article.
-
Piperlongumine is a ligand for the orphan nuclear receptor 4A1 (NR4A1).Front Pharmacol. 2023 Sep 21;14:1223153. doi: 10.3389/fphar.2023.1223153. eCollection 2023. Front Pharmacol. 2023. PMID: 37808182 Free PMC article.
-
Analysis of an antioxidative defence system of hydrogen peroxide-treated pancreatic islet-derived 1.1B4 cells and siRNA targeting NR4A3-treated cells by microarray.Redox Rep. 2023 Dec;28(1):2247150. doi: 10.1080/13510002.2023.2247150. Redox Rep. 2023. PMID: 37581334 Free PMC article.
References
-
- Milbrandt J. Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron. 1988;1:183–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous